Stocksigma LogoStocksigma Logo

Beryl Drugs Schedules Board Meeting to Approve Q2 Results

Beryl Drugs Limited has scheduled its Board of Directors meeting for 14th Nov'26 to consider and approve the unaudited financial results and the Limited

Beryl Drugs Schedules Board Meeting to Approve Q2 Results

Beryl Drugs Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Beryl Drugs Schedules Board Meeting to Approve Q2 Results Beryl Drugs Limited has scheduled its Board of Directors meeting for 14th Nov'26 to consider and approve the unaudited financial results and the Limited Review Report for the quarter ended 30th Sep'26. Consequently, the trading window for dealing in the company鈥檚 securities, which has been closed since 1st Jul'26 pursuant to SEBI Insider Trading Regulations, will reopen 48 hours after the conclusion of the board meeting.

Original exchange filing (PDF)

More announcements from Beryl Drugs Ltd

All Beryl Drugs Ltd announcements